Today, the firm partnered with Pomerantz LLP to file the opening brief in an appeal in a securities fraud case involving generic pharmaceutical makers.
Opening Brief in Second Circuit Securities Fraud Appeal
Previous
Previous
Eleventh Circuit Declines to Rehear Firm’s Copyright Victory Against Apple
Next
Next